Capital Structure Decisions in Swedish Biotechnology Firms: The Role of Intellectual Capital and Innovation Activities
Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and innova...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2025-03-01
|
| Ráidu: | International Journal of Financial Studies |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2227-7072/13/1/43 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|